Lungcancer drug 'extends life'by
of the 39,750 lungcancer patients in the UK fall into the category of being too ill for chemotherapy... cell lungcancer who are unsuitable for first-line chemotherapy."
The drug is licensed...
New cancer drug nearing the end ...by
the evaluation process for the new potential cancer drug to treat prostate, lung and breast cancer.... OGX-011 is currently completing five Phase 2 clinical studies in prostate, lung and breast cancer...